Analysis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis isolates in Morocco using GenoType® MTBDRplus assay
Authors:
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 12, 197-201
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugsJournal of Antimicrobial Chemotherapy, 2011
- Tuberculosis Drug Resistance in an Area of Low Endemicity in 2004 to 2006: Semiquantitative Drug Susceptibility Testing and GenotypingJournal of Clinical Microbiology, 2008
- Genotype MTBDR plus : a Further Step toward Rapid Identification of Drug-Resistant Mycobacterium tuberculosisJournal of Clinical Microbiology, 2008
- Evaluation of the GenoType MTBDRplus Assay for Rifampin and Isoniazid Susceptibility Testing of Mycobacterium tuberculosis Strains and Clinical SpecimensJournal of Clinical Microbiology, 2007
- Performance of the Genotype MTBDR Line Probe Assay for Detection of Resistance to Rifampin and Isoniazid in Strains of Mycobacterium tuberculosis with Low- and High-Level ResistanceJournal of Clinical Microbiology, 2006
- Use of Genotype MTBDR Assay for Molecular Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Clinical Strains Isolated in ItalyJournal of Clinical Microbiology, 2006
- Mutations in the rpoB Gene of Multidrug-Resistant Mycobacterium tuberculosis Isolates from ChinaJournal of Clinical Microbiology, 2003
- High Prevalence of KatG Ser315Thr Substitution among Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates from Northwestern Russia, 1996 to 2001Antimicrobial Agents and Chemotherapy, 2002
- Detection of rifampicin-resistance mutations in Mycobacterium tuberculosisThe Lancet, 1993
- The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosisNature, 1992